There are 2867 resources available
58P - Spectrum of germline pathogenic mutations in 1087 Chinese patients with biliary tract cancer
Presenter: jun Shen
Session: Poster session 13
59P - Efficacy of derazantinib in intrahepatic cholangiocarcinoma (iCCA) patients with FGFR2 fusions, mutations or amplifications
Presenter: Mitesh Borad
Session: Poster session 13
60P - A phase II trial of hepatic arterial infusion chemotherapy and bevacizumab in combination with toripalimab for advanced biliary tract cancers: Interim report
Presenter: Xiaodong Wang
Session: Poster session 13
61P - Clinical and molecular characterisation of IDH1/2 mutant cholangiocarcinoma
Presenter: Florian Castet
Session: Poster session 13
62P - Proteomic and single-cell landscape reveals novel pathogenic mechanisms of HBV-infected intrahepatic cholangiocarcinoma
Presenter: Xu Shuaishuai
Session: Poster session 13
63P - Intrahepatic cholangiocarcinoma (iCCA) genomic findings with high versus low tumor mutational burdens
Presenter: Tin-Yun Tang
Session: Poster session 13
64P - Phase I/II study of nivolumab plus lenvatinib for advanced biliary tract cancer (JCOG1808/NCCH1817, SNIPE)
Presenter: Makoto Ueno
Session: Poster session 13
461P - Overview of patients inclusions and outcomes into modern phase I trials at Gustave Roussy over the last 5 years, OVATION study
Presenter: Emily Alouani
Session: Poster session 13
462P - TYRA-300: FGFR3 selective and gatekeeper agnostic
Presenter: Jacqueline Starrett
Session: Poster session 13